Company:  NATERA, INC. (NTRA)
Form Type:  4
Filing Date:  7/9/2021 
CIK:  0001604821 
Address:  13011 MCCALLEN PASS
BUILDING A SUITE 100
 
City, State, Zip:  AUSTIN, Texas 78753 
Telephone:  650-249-9090 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$113.67  
Change: 
2.28 (2.05%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$10.66B
Trade NTRA now with 

© 2021  
Description of Business
We are a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change the management of disease worldwide. Our cell-free DNA, or cfDNA, technology combines our novel molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell, with our statistical algorithms which incorporate data available from the broader scientific community to identify genetic variations covering a wide range of serious conditions with best-in-class accuracy and coverage. Our technology has been proven clinically and commercially in the women's health space, in which we develop and commercialize non- or minimally- invasive tests to evaluate risk for, and thereby enable early detection of, a wide range of genetic conditions, such as Down syndrome.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES